|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
15,080,000 |
Market
Cap: |
25.18(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.42 - $2.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
29,258 |
Total Buy Value |
$0 |
$0 |
$0 |
$67,776 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
476 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Galante Joseph C |
Director |
|
2022-07-18 |
4 |
AB |
$2.41 |
$178 |
D/D |
74 |
49,512 |
|
4% |
|
Young Caroline |
Director |
|
2022-07-15 |
4 |
AB |
$2.23 |
$60 |
D/D |
27 |
17,213 |
|
0% |
|
Krogulski Kenneth |
Director |
|
2022-07-15 |
4 |
AB |
$2.23 |
$321 |
D/D |
144 |
191,472 |
|
0% |
|
Jones James |
Director |
|
2022-07-15 |
4 |
AB |
$2.23 |
$96 |
D/D |
43 |
22,529 |
|
0% |
|
Galante Joseph C |
Director |
|
2022-07-15 |
4 |
AB |
$2.23 |
$192 |
D/D |
86 |
49,438 |
|
0% |
|
Brown Martin S Jr |
Director |
|
2022-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,000 |
|
0% |
|
Young Caroline |
Director |
|
2022-07-14 |
4 |
AB |
$2.28 |
$62 |
D/D |
27 |
17,186 |
|
- |
|
Krogulski Kenneth |
Director |
|
2022-07-14 |
4 |
AB |
$2.28 |
$328 |
D/D |
144 |
191,328 |
|
- |
|
Jones James |
Director |
|
2022-07-14 |
4 |
AB |
$2.28 |
$98 |
D/D |
43 |
22,486 |
|
- |
|
Galante Joseph C |
Director |
|
2022-07-14 |
4 |
AB |
$2.28 |
$196 |
D/D |
86 |
49,352 |
|
- |
|
Young Caroline |
Director |
|
2022-07-12 |
4 |
AB |
$2.25 |
$61 |
D/D |
27 |
17,159 |
|
- |
|
Krogulski Kenneth |
Director |
|
2022-07-12 |
4 |
AB |
$2.25 |
$324 |
D/D |
144 |
191,184 |
|
- |
|
Jones James |
Director |
|
2022-07-12 |
4 |
AB |
$2.25 |
$97 |
D/D |
43 |
22,443 |
|
- |
|
Galante Joseph C |
Director |
|
2022-07-12 |
4 |
AB |
$2.25 |
$194 |
D/D |
86 |
49,266 |
|
- |
|
Young Caroline |
Director |
|
2022-07-08 |
4 |
AB |
$2.21 |
$60 |
D/D |
27 |
17,132 |
|
5% |
|
Krogulski Kenneth |
Director |
|
2022-07-08 |
4 |
AB |
$2.19 |
$315 |
D/D |
144 |
191,040 |
|
5% |
|
Jones James |
Director |
|
2022-07-08 |
4 |
AB |
$2.21 |
$95 |
D/D |
43 |
22,400 |
|
5% |
|
Galante Joseph C |
Director |
|
2022-07-08 |
4 |
AB |
$2.19 |
$188 |
D/D |
86 |
49,180 |
|
5% |
|
Young Caroline |
Director |
|
2022-07-07 |
4 |
AB |
$2.18 |
$59 |
D/D |
27 |
17,105 |
|
7% |
|
Krogulski Kenneth |
Director |
|
2022-07-07 |
4 |
AB |
$2.18 |
$314 |
D/D |
144 |
190,896 |
|
7% |
|
Jones James |
Director |
|
2022-07-07 |
4 |
AB |
$2.18 |
$94 |
D/D |
43 |
22,357 |
|
7% |
|
Galante Joseph C |
Director |
|
2022-07-07 |
4 |
AB |
$2.18 |
$187 |
D/D |
86 |
49,094 |
|
7% |
|
Young Caroline |
Director |
|
2022-07-06 |
4 |
AB |
$2.11 |
$57 |
D/D |
27 |
17,078 |
|
8% |
|
Krogulski Kenneth |
Director |
|
2022-07-06 |
4 |
AB |
$2.11 |
$304 |
D/D |
144 |
190,752 |
|
8% |
|
Jones James |
Director |
|
2022-07-06 |
4 |
AB |
$2.11 |
$91 |
D/D |
43 |
22,314 |
|
8% |
|
1400 Records found
|
|
Page 13 of 56 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|